The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
104283664 10428366 4 F 20130716 20160824 20140903 20160901 EXP US-ASTRAZENECA-2013SE62390 ASTRAZENECA 68.00 YR M Y 135.00000 KG 20160901 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
104283664 10428366 1 PS IBUPROFEN. IBUPROFEN 1 Oral TID Y 0 TABLET
104283664 10428366 2 SS IBUPROFEN. IBUPROFEN 1 Oral TID Y 0 TABLET
104283664 10428366 3 SS NEXIUM ESOMEPRAZOLE MAGNESIUM 1 Oral 20 MG, 1X/DAY 1420 MG Y 0 20 MG QD
104283664 10428366 4 SS LISINOPRIL. LISINOPRIL 1 Oral 40 MG, QD 153440 MG Y 0 40 MG QD
104283664 10428366 5 SS HYDROCHLOROTHIAZIDE. HYDROCHLOROTHIAZIDE 1 Oral 25 MG, QD 95900 MG Y 0 25 MG QD
104283664 10428366 6 SS FUROSEMIDE. FUROSEMIDE 1 Oral 20 MG, QD 76720 MG Y 0 20 MG QD
104283664 10428366 7 SS SIMVASTATIN. SIMVASTATIN 1 Oral 40 MG, QHS 153440 MG 0 40 MG QD
104283664 10428366 8 C INSULIN GLARGINE INSULIN GLARGINE 1 Intramuscular 60 UNITS, QD 0 60 IU QD
104283664 10428366 9 C OMEPRAZOLE. OMEPRAZOLE 1 Oral 20 MG, QD 0 20 MG QD
104283664 10428366 10 C OXYBUTYNIN OXYBUTYNIN 1 Oral 5 MG, QD 0 5 MG QD
104283664 10428366 11 C CIALIS TADALAFIL 1 Oral 20 MG, PRN 0 20 MG
104283664 10428366 12 C CINNAMON. CINNAMON 1 Oral 2000 MG, QD 0 2000 MG QD
104283664 10428366 13 C PERCOCET ACETAMINOPHENOXYCODONE HYDROCHLORIDE 1 Oral 10 MG, PRN 0 10 MG
104283664 10428366 14 C ASPIRIN. ASPIRIN 1 Oral 81 MG, QD 0 81 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
104283664 10428366 1 Osteoarthritis
104283664 10428366 2 Rheumatoid arthritis
104283664 10428366 3 Prophylaxis
104283664 10428366 4 Hypertension
104283664 10428366 5 Hypertension
104283664 10428366 6 Oedema
104283664 10428366 7 Dyslipidaemia
104283664 10428366 8 Type 2 diabetes mellitus
104283664 10428366 9 Gastrooesophageal reflux disease
104283664 10428366 10 Urinary incontinence
104283664 10428366 11 Erectile dysfunction
104283664 10428366 12 Medical diet
104283664 10428366 13 Arthralgia
104283664 10428366 14 Cardiovascular event prophylaxis

Outcome of event

Event ID CASEID OUTC COD
104283664 10428366 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
104283664 10428366 Acute kidney injury
104283664 10428366 Non-cardiac chest pain

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
104283664 10428366 1 20130507 20130716 0
104283664 10428366 2 20130507 20130716 0
104283664 10428366 3 20130507 20130716 0
104283664 10428366 4 200301 20130716 0
104283664 10428366 5 200301 20130716 0
104283664 10428366 6 200301 20130716 0
104283664 10428366 7 200301 0
104283664 10428366 8 200301 0
104283664 10428366 9 200301 0
104283664 10428366 10 200801 0
104283664 10428366 11 200801 0
104283664 10428366 12 201202 0
104283664 10428366 13 201303 0
104283664 10428366 14 199801 0